Book your demo

Want to know how Resilience Care can support your teams and projects? Contact us !

Category

Oncology
Online Conferences

Written by

Summary

Title

Resilience Conference: Patient Reported Outcomes in Research and the revolution of AI

Discover with Prof. di Maio & Prof. Massard how Patient Reported Outcomes (PROs) are becoming key to include QoL as endpoints in phase III oncology trials and the paradigm shift in early-phase trials using PROs for dose optimization.

Dec 4, 2025

15 minutes

Discover in this conference how Patient Reported Outcomes (PROs) are transforming oncology research.

Learn with :

  • Professor Massimo di Maio the Importance of PROs in Phase III Clinical Trials: Integrating Quality of Life (QoL) as a key endpoint in oncology trials.
  • Professor Christophe Massard the paradigm Shift in Early-Phase Trials: The use of PROs for dose optimization in early-phase trials, specifically through the Project Optimus approach.

Register to access the conference replay.

Heading

Resilience Conference: Patient Reported Outcomes in Research and the revolution of AI

Discover with Prof. di Maio & Prof. Massard how Patient Reported Outcomes (PROs) are becoming key to include QoL as endpoints in phase III oncology trials and the paradigm shift in early-phase trials using PROs for dose optimization.

Dec 4, 2025

15 minutes

Discover in this conference how Patient Reported Outcomes (PROs) are transforming oncology research.

Learn with :

  • Professor Massimo di Maio the Importance of PROs in Phase III Clinical Trials: Integrating Quality of Life (QoL) as a key endpoint in oncology trials.
  • Professor Christophe Massard the paradigm Shift in Early-Phase Trials: The use of PROs for dose optimization in early-phase trials, specifically through the Project Optimus approach.

Register to access the conference replay.

Resilience Conference: Patient Reported Outcomes in Research and the revolution of AI

Discover with Prof. di Maio & Prof. Massard how Patient Reported Outcomes (PROs) are becoming key to include QoL as endpoints in phase III oncology trials and the paradigm shift in early-phase trials using PROs for dose optimization.

Dec 4, 2025

15 minutes

Discover in this conference how Patient Reported Outcomes (PROs) are transforming oncology research.

Learn with :

  • Professor Massimo di Maio the Importance of PROs in Phase III Clinical Trials: Integrating Quality of Life (QoL) as a key endpoint in oncology trials.
  • Professor Christophe Massard the paradigm Shift in Early-Phase Trials: The use of PROs for dose optimization in early-phase trials, specifically through the Project Optimus approach.

Register to access the conference replay.

Resilience Conference: Patient Reported Outcomes in Research and the revolution of AI

Discover with Prof. di Maio & Prof. Massard how Patient Reported Outcomes (PROs) are becoming key to include QoL as endpoints in phase III oncology trials and the paradigm shift in early-phase trials using PROs for dose optimization.

Dec 4, 2025

15 minutes

Discover in this conference how Patient Reported Outcomes (PROs) are transforming oncology research.

Learn with :

  • Professor Massimo di Maio the Importance of PROs in Phase III Clinical Trials: Integrating Quality of Life (QoL) as a key endpoint in oncology trials.
  • Professor Christophe Massard the paradigm Shift in Early-Phase Trials: The use of PROs for dose optimization in early-phase trials, specifically through the Project Optimus approach.

Register to access the conference replay.

Resilience Conference: Patient Reported Outcomes in Research and the revolution of AI

Discover with Prof. di Maio & Prof. Massard how Patient Reported Outcomes (PROs) are becoming key to include QoL as endpoints in phase III oncology trials and the paradigm shift in early-phase trials using PROs for dose optimization.

Dec 4, 2025

15 minutes

Discover in this conference how Patient Reported Outcomes (PROs) are transforming oncology research.

Learn with :

  • Professor Massimo di Maio the Importance of PROs in Phase III Clinical Trials: Integrating Quality of Life (QoL) as a key endpoint in oncology trials.
  • Professor Christophe Massard the paradigm Shift in Early-Phase Trials: The use of PROs for dose optimization in early-phase trials, specifically through the Project Optimus approach.

Register to access the conference replay.

Speakers:

Prof. Massimo di Maio
Medical Oncologist — Head of the Medical Oncology Unit at Molinette Hospital — Professor at Turin's University — President-elect of AIOM
Turin, Italy
Pr. Christophe Massard
Oncologue médical, Chef du Département de l'Innovation Thérapeutique et des Essais Précoces (DITEP)
Gustave Roussy

Related articles

Oncology
Testimonials

Pioneering Early Phase Trials: PROs and Dose Optimization

Dec 4, 2025

3 minutes

Oncology
Online Conferences

Resilience Conference: Patient Reported Outcomes in Research and the revolution of AI

Dec 4, 2025

15 minutes

Oncology
Testimonials

Improving Cancer Care: The Power of Remote Patient Monitoring (RPM)

Dec 4, 2025

2 minutes

Ready to Implement 
Resilience in your Facility ?

Let’s discuss how our solutions can help you unlock the full potential of your data and improve patient outcomes.